Holen Sie sich die Stockscreener-App
9.7965
0.38%
-0.0535
Schlusskurs vom Vortag:
$9.85
Offen:
$9.85
24-Stunden-Volumen:
2.13M
Relative Volume:
0.43
Marktkapitalisierung:
$3.02B
Einnahmen:
$571.16M
Nettoeinkommen (Verlust:
$-38.10M
KGV:
-79.97
EPS:
-0.1225
Netto-Cashflow:
$-48.91M
1W Leistung:
+0.85%
1M Leistung:
+10.63%
6M Leistung:
+62.73%
1J Leistung:
-0.18%
1-Tages-Spanne:
$9.79
$9.935
1-Wochen-Bereich:
$9.6344
$10.05
52-Wochen-Spanne:
$5.51
$10.57
Amicus Therapeutics Inc Stock (FOLD) Company Profile
Firmenname
Amicus Therapeutics Inc
Sektor
Branche
Telefon
(609) 662-2000
Adresse
47 HULFISH STREET, PRINCETON, NJ
Vergleichen Sie FOLD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FOLD
Amicus Therapeutics Inc
|
9.795 | 3.04B | 571.16M | -38.10M | -48.91M | -0.1225 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Hochstufung | Needham | Hold → Buy |
| 2025-07-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-06 | Eingeleitet | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Wells Fargo | Overweight |
| 2024-05-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-12-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Fortgesetzt | Goldman | Neutral |
| 2022-01-14 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-15 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-07-19 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Hold |
| 2021-05-21 | Eingeleitet | UBS | Buy |
| 2021-04-14 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2021-02-12 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-11-11 | Eingeleitet | Berenberg | Hold |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-02-04 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-11-12 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-06-05 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2019-01-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-10-29 | Eingeleitet | Citigroup | Neutral |
| 2018-08-17 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2017-10-06 | Fortgesetzt | Goldman | Neutral |
| 2017-09-13 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-08-10 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2016-05-18 | Eingeleitet | BofA/Merrill | Buy |
| 2016-04-14 | Eingeleitet | Robert W. Baird | Neutral |
| 2016-04-12 | Bestätigt | Chardan Capital Markets | Buy |
| 2015-09-16 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2015-06-16 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten
Jump Financial LLC Raises Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
How Amicus Therapeutics Inc. (FOLD) Affects Rotational Strategy Timing - news.stocktradersdaily.com
3,235,538 Shares in Amicus Therapeutics, Inc. $FOLD Bought by Norges Bank - MarketBeat
Amicus Therapeutics, Inc. $FOLD Shares Sold by JPMorgan Chase & Co. - MarketBeat
Can Galafold continue to drive Amicus' top line in 2026? - MSN
Amicus Therapeutics, Inc. $FOLD Shares Sold by Prudential Financial Inc. - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Surging Earnings Estimates Signal Upside for Amicus Therapeutics (FOLD) Stock - Finviz
Can Galafold Continue to Drive Amicus' Top Line in 2026? - Eastern Progress
Schroder Investment Management Group Purchases 649,177 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
What is the fair value estimate for Amicus Therapeutics Inc. (AM6) stock in 2025Quarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - Newser
Amicus Therapeutics (NASDAQ:FOLD) CEO Sells 14,587 Shares - MarketBeat
Is Amicus Therapeutics Inc. (AM6) stock nearing a technical breakout2025 Analyst Calls & Consistent Profit Trade Alerts - Newser
BMY Gains on News of Continuation of Alzheimer's Disease Study - Finviz
Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
How Amicus Therapeutics Inc. (AM6) stock performs in volatility spikes2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser
Pompe Disease Treatment Market is expected to reach US$ 4.06 - openPR.com
Amicus Therapeutics CEO Sells Shares - TradingView
What analysts say about Amicus Therapeutics Inc stockStock Valuation Metrics & We Spotted the Next Tesla – See Inside - earlytimes.in
Will Amicus Therapeutics Inc. (AM6) stock benefit from mergersLong Setup & Safe Capital Growth Stock Tips - Newser
Capital Fund Management S.A. Has $4.37 Million Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Will Amicus Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Highlights & Reliable Entry Point Trade Alerts - Newser
Why Amicus Therapeutics Inc. (AM6) stock could break out in 2025Recession Risk & Daily Profit Maximizing Tips - Newser
Amicus Therapeutics, Inc. $FOLD Stock Position Raised by Virtus Investment Advisers LLC - MarketBeat
Creative Planning Purchases 180,652 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Advantage Alpha Capital Partners LP Makes New Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Assessing Amicus Therapeutics (FOLD) Valuation as Shares Gain 11% Over Past Month - Yahoo Finance
How Strong Galafold and Pombiliti Sales Helped Amicus Therapeutics (FOLD) Surpass Expectations and Shift Its Outlook - Yahoo Finance
Intech Investment Management LLC Sells 47,907 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc. $FOLD Stock Holdings Increased by Jefferies Financial Group Inc. - MarketBeat
Geode Capital Management LLC Sells 57,278 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Envestnet Asset Management Inc. Has $368,000 Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
David Michael Clark Sells 25,643 Shares of Amicus Therapeutics (NASDAQ:FOLD) Stock - MarketBeat
Insider Selling: Amicus Therapeutics (NASDAQ:FOLD) CEO Sells 14,587 Shares of Stock - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Acquires 95,565 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Insider Ellen Rosenberg Sells 23,621 Shares - MarketBeat
Insider Sell Alert: David Clark Sells 25,643 Shares of Amicus Th - GuruFocus
Amicus Therapeutics chief legal officer sells $958k in stock By Investing.com - Investing.com Canada
Amicus Therapeutics chief people officer sells $258,932 in stock By Investing.com - Investing.com Canada
Wall Street Analysts Think Amicus Therapeutics (FOLD) Could Surge 58.46%: Read This Before Placing a Bet - Finviz
Officer Clark Sells 25,643 ($258.9K) Of Amicus Therapeutics Inc [FOLD] - TradingView
CEO Campbell Sells 14,587 ($146.5K) Of Amicus Therapeutics Inc [FOLD] - TradingView
Officer Rosenberg Sells 95,621 ($958.5K) Of Amicus Therapeutics Inc [FOLD] - TradingView
Amicus Therapeutics Executives Sell Shares - TradingView
Amicus Therapeutics (NASDAQ:FOLD) Sets New 12-Month HighWhat's Next? - MarketBeat
AXQ Capital LP Makes New $290,000 Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Officer Castelli Files To Sell 76,158 Of Amicus Therapeutics Inc [FOLD] - TradingView
Amicus Therapeutics stock hits 52-week high at $10.36 By Investing.com - Investing.com Nigeria
Amicus Therapeutics stock hits 52-week high at $10.36 - Investing.com
Amicus Therapeutics Inc AM6 Stock Analysis and ForecastIndustrial Stocks Review & Rapid Profit Growth - earlytimes.in
Primecap Management Co. CA Sells 123,400 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Finanzdaten der Amicus Therapeutics Inc-Aktie (FOLD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):